首页> 外文期刊>Coordination chemistry reviews >Biomarker-activatable probes based on smart AIEgens for fluorescence and optoacoustic imaging
【24h】

Biomarker-activatable probes based on smart AIEgens for fluorescence and optoacoustic imaging

机译:Biomarker-activatable probes based on smart AIEgens for fluorescence and optoacoustic imaging

获取原文
获取原文并翻译 | 示例
       

摘要

Fluorophores with aggregation-induced emission (AIE) are characterized by many advantageous features for biomedical applications, including excellent photostability and enhanced fluorescent emission in aqueous milieu with minimal aggregation caused quenching (ACQ) effect. The abnormal levels of biomarkers are closely correlated with various diseases. Hence developing new strategies for detection and imaging of disease biomarkers fluorescently and optoacoustically is of high significance for early diagnosis of diseases. Probes (contrast agents) play essential roles in fluorescent and optoacoustic imaging. They have been extensively explored and applied in recent years, which induce the emergence of a variety of new probes in particular the biomarker-activatable probes based on smart AIEgens for fluorescence and optoacoustic imaging. In this review, we aim to summarize the latest development and progress as well as biomedical applications of the biomarker-activatable probes based on smart AIEgens. We focus on their design strategies and highlight the prospects and challenges in fluorescent and optoacoustic imaging.(c) 2022 Elsevier B.V. All rights reserved.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号